Filing Flows

Filing Flows › Companies › Dolby Laboratories › Timeline

Dolby Laboratories stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+2.0% to $64.83

Dolby Laboratories (DLB) stock rose 2% over the last 252 sessions, to $64.83. On the way it reported 4 quarters, its insiders filed 7 open-market trades and 7 Form 144 notices of planned sales, and the company filed 2 material 8-Ks. Each is marked on the price and listed with what the stock did next.

DLB: a year of the stock with every disclosure on itDLB: a year of the stock with every disclosure on it$52.46$58.27$64.07$69.88◆2025-11-14 · Directors and officers: departures, appointments, pay●2025-11-18 · Earnings: beat the EPS estimate by 40.4%▼2025-11-20 · Couling John D sold $408K●2026-01-29 · Earnings: beat the EPS estimate by 6.7%▼2026-02-02 · Couling John D sold $433K▼2026-02-13 · Nicholson Ryan sold $177K●2026-04-30 · Earnings: beat the EPS estimate by 2.5%▼2026-05-22 · Pendleton Todd sold $648K▽2026-07-01 · Form 144: John Couling plans to sell $408K●2026-07-30 · Earnings: beat the EPS estimate by 3.0%▽2026-08-03 · Form 144: John Couling plans to sell $460K▼2026-08-04 · Nicholson Ryan sold $22K▼2026-08-10 · Nicholson Ryan sold $84K▽2026-08-10 · Form 144: Ryan H Nicholson plans to sell $84K▽2026-08-14 · Form 144: Shriram Revankar plans to sell $188K▼2026-08-25 · Nicholson Ryan sold $77K▽2026-08-25 · Form 144: Ryan H Nicholson plans to sell $77K◆2026-08-27 · Directors and officers: departures, appointments, pay▽2026-09-01 · Form 144: John Couling plans to sell $468K▽2026-10-01 · Form 144: John Couling plans to sell $451K◆8-K event●Earnings report▼Insider sale▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Oct 1, 2026Form 144Form 144: John Couling plans to sell $451K+0.5% (+0.3% vs SPY)−0.7% (−2.6% vs SPY)+6.8% (+5.9% vs SPY)
Sep 1, 2026Form 144Form 144: John Couling plans to sell $468K−0.2% (+0.5% vs SPY)+1.2% (+1.4% vs SPY)−4.7% (−4.3% vs SPY)
Aug 27, 20268-KDirectors and officers: departures, appointments, pay−4.0% (−4.6% vs SPY)−5.0% (−4.9% vs SPY)−10.4% (−11.3% vs SPY)
Aug 25, 2026Form 144Form 144: Ryan H Nicholson plans to sell $77K+0.1% (−0.2% vs SPY)−7.0% (−7.5% vs SPY)−13.0% (−13.8% vs SPY)
Aug 25, 2026Insider saleNicholson Ryan sold $77K+0.1% (−0.2% vs SPY)−7.0% (−7.5% vs SPY)−13.0% (−13.8% vs SPY)
Aug 14, 2026Form 144Form 144: Shriram Revankar plans to sell $188K0.0% (+0.2% vs SPY)+2.9% (+4.9% vs SPY)−0.7% (+1.5% vs SPY)
Aug 10, 2026Form 144Form 144: Ryan H Nicholson plans to sell $84K+0.5% (+0.6% vs SPY)+1.6% (+1.2% vs SPY)+1.5% (+2.4% vs SPY)
Aug 10, 2026Insider saleNicholson Ryan sold $84K+0.5% (+0.6% vs SPY)+1.6% (+1.2% vs SPY)+1.5% (+2.4% vs SPY)
Aug 4, 2026Insider saleNicholson Ryan sold $22K+2.5% (+0.7% vs SPY)+3.9% (+1.9% vs SPY)+3.4% (+2.8% vs SPY)
Aug 3, 2026Form 144Form 144: John Couling plans to sell $460K+1.6% (+0.1% vs SPY)+4.9% (+1.5% vs SPY)+5.1% (+2.5% vs SPY)
Jul 30, 2026EarningsEarnings: beat the EPS estimate by 3.0%−1.5% (−3.1% vs SPY)+15.5% (+10.1% vs SPY)+17.8% (+12.2% vs SPY)
Jul 1, 2026Form 144Form 144: John Couling plans to sell $408K0.0% (+0.2% vs SPY)−5.3% (−5.1% vs SPY)−1.6% (−0.9% vs SPY)
May 22, 2026Insider salePendleton Todd sold $648K+1.2% (+0.8% vs SPY)+3.2% (+1.4% vs SPY)−3.7% (−2.7% vs SPY)
Apr 30, 2026EarningsEarnings: beat the EPS estimate by 2.5%+1.4% (+0.4% vs SPY)−8.7% (−11.8% vs SPY)−11.9% (−18.0% vs SPY)
Feb 13, 2026Insider saleNicholson Ryan sold $177K−0.8% (−0.9% vs SPY)−4.0% (−5.2% vs SPY)−8.4% (−6.6% vs SPY)
Feb 2, 2026Insider saleCouling John D sold $433K+0.5% (0.0% vs SPY)+1.0% (+1.2% vs SPY)+1.4% (+3.1% vs SPY)
Jan 29, 2026EarningsEarnings: beat the EPS estimate by 6.7%+3.0% (+3.2% vs SPY)+5.2% (+6.6% vs SPY)+9.0% (+10.3% vs SPY)
Nov 20, 2025Insider saleCouling John D sold $408K+0.8% (+2.3% vs SPY)+3.0% (+0.5% vs SPY)+2.4% (−0.5% vs SPY)
Nov 18, 2025EarningsEarnings: beat the EPS estimate by 40.4%+0.6% (+1.5% vs SPY)+3.4% (+2.9% vs SPY)+4.4% (+3.6% vs SPY)
Nov 14, 20258-KDirectors and officers: departures, appointments, pay−1.6% (−0.6% vs SPY)+2.9% (+4.8% vs SPY)+2.4% (+1.4% vs SPY)

Insiders’ record here

In the year on the chart, Dolby Laboratories' insiders reported 0 open-market buys ($0) and 7 sales ($1.8M). Of the 6 old enough to score, 3 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale +5.9%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Dolby Laboratories: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.